DENMARK – Novozymes and Novo Nordisk Pharmatech have announced a collaboration agreement that brings together the companies’ shared competencies and interests in the development of specialty enzymes for use in…
Read MoreTag: Codexis
Codexis completes its license transfer of its codeevolver technology to Novartis for non-exclusive use
US – Codexis, a leading enzyme engineering company enabling the promise of synthetic biology, has completed the transfer of its CodeEvolver platform technology with Novartis. The transfer comes two years…
Read MoreCodexis receives milestone payment from GlaxoSmithKline as it focuses on commercializing its CodeEvolver technology
WORLD – Codexis, a leading enzyme engineering company, has received a huge sum of money from GlaxoSmithKline (GSK), a drug manufacturing giant, in a deal that will provide GSK licensing…
Read More